Brief: Protagenic Says Entered Into At Market Issuance Sales Agreement With B. Riley Securities, EF Hutton
02/07/2021 23:33
July 2 (Reuters) - Protagenic Therapeutics Inc PTIX.O :
* PROTAGENIC THERAPEUTICS - ON JULY 2 ENTERED INTO AT MARKET
ISSUANCE SALES AGREEMENT WITH B. RILEY SECURITIES AND EF HUTTON
* PROTAGENIC THERAPEUTICS - UNDER SALES AGREEMENT MAY OFFER
&
SELL, FROM TIME TO TIME, THROUGH AGENTS, SHARES OF COMMON STOCK
OF UP TO $10 MILLION
Further company coverage: PTIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Protagenic Therapeutics
See all newsBrief: Protagenic Therapeutics Inc - Alexander Arrow, CFO, To Be Terminated Effective April 30, 2026 - SEC Filing
Brief: Protagenic Therapeutics Approves Restructuring Plan on August 8- SEC Filing
Brief: Protagenic Therapeutics Granted Japanese Patent JP 7714571B
Brief: Protagenic Therapeutics Enters Share Exchange Agreement With Alterola And EMC2 - SEC Filing
Brief: Protagenic Therapeutics - May Offer And Sell, From Time To Time, Shares Of Common Stock Of Up To $1.2 Mln